Investor Profile: Parkway Venture Capital — Thesis, Cheque Size & How to Apply

Parkway Venture Capital is a New York-based venture firm founded in 2019 by managing partners Gregg Hill and Jesse Coors-Blankenship, with offices in New York and Winter Park, Florida. Parkway backs fundamentally disruptive technologies and runs a deliberately concentrated book: it leads rounds, takes board involvement, partners closely with a small group of founders and holds its positions. In October 2026 it ranked No. 1 among US emerging venture firms in the Stanford Strebulaev–Jackson ranking, and in the top 20 among all US venture firms, despite being one of the youngest firms on the list.

What Parkway invests in

Parkway's stated focus areas are Artificial Intelligence, Simulation, Quantum Tech, Ubiquitous Data and Complex Engineering. The portfolio on its own site lists Figure AI, SandboxAQ, Pasqal, xAI, Hark, TAE Technologies, OXOS Medical, Persefoni, TestFit, Gemba and Wambi. Its own press release documents how early and how large it goes: it led Figure AI's $70 million Series A in 2023 and its multi-billion-dollar Series C in 2025, was the first venture backer of SandboxAQ after its 2022 spin-out from Google, backed xAI's $6 billion Series B in 2024, and led a $2 billion Series A in AI lab Hark in 2026.

Cheque size and deal pace

The firm does not publish a standard cheque size, and the large figures above are total round sizes it led or joined, not Parkway's own cheques — founders should not read them as a cheque range. On pace, Parkway is explicit that concentration is the model: "you cannot be that involved in 200 companies," its co-founder says. Its public portfolio numbers around a dozen companies since 2019, so there is no high-volume deal average to quote — this is a handful of deep partnerships at a time, not a spray-and-pray fund.

Notable exits

Parkway's clearest documented exit is Pasqal, the French neutral-atom quantum computing company it backed before consensus: Pasqal completed its business combination in August 2026 and began trading on Nasdaq as PSQL, in a transaction valuing it at roughly $2 billion, with shares rising as much as 73% on day one. The firm's own press release boilerplate also lists its 2026 investment exits as including xAI and TAE Technologies alongside Pasqal. Its specialty is conviction in deep tech — humanoid robots, quantum and fusion — before those categories become obvious.

How to apply for funding

Parkway runs no accelerator, fellowship or open application programme, and publishes no pitch form. Founders reach the firm through its website at parkway.vc and through warm introductions in the AI and deep-tech community. Given the concentrated model, the realistic route is a direct, well-referenced approach to a managing partner with a technology that is genuinely category-creating — Parkway's record is built on backing companies before they were consensus.